Gtree Pharmaceuticals

Q: What is Gtree Pharmaceuticals's official website?

Gtree Pharmaceuticals's official website is www.gtreepharma.com

Q: What is Gtree Pharmaceuticals's Revenue?

Gtree Pharmaceuticals's revenue is <$5 Million

Q: What is Gtree Pharmaceuticals's SIC code?

Gtree Pharmaceuticals's SIC: 28,283

Q: What is Gtree Pharmaceuticals's NAICS code?

Gtree Pharmaceuticals's NAICS: 32,325

Q: How many employees does Gtree Pharmaceuticals have?

Gtree Pharmaceuticals has 11-50 employees

Q: What industry does Gtree Pharmaceuticals belong to?

Gtree Pharmaceuticals is in the industry of: Manufacturing , Pharmaceuticals , Business Services

Q: What is Gtree Pharmaceuticals competition?

Gtree Pharmaceuticals top competitors include: OccuRx , PolyActiva , Clarity Pharmaceuticals , Pharmatechno

Q: What technology does Gtree Pharmaceuticals use?

Some of the popular technologies that Gtree Pharmaceuticals uses are: WooCommerce, WordPress.org, PHP, Google Font API

Q: What does Gtree Pharmaceuticals do?

Gtree Pharmaceuticals is a biopharmaceutical company established in June 2014, focusing on the development of innovative drugs for ophthalmic and rare diseases. The company is currently conducting clinical trials for its lead product, GBT-201, aimed at treating dry eye syndrome and neurotrophic keratitis. Gtree Pharmaceuticals targets both domestic... and international markets, particularly in South Korea and the United States. Their commitment to research and development positions them as a key player in the biopharmaceutical industry. Read More

Q: Is Gtree Pharmaceuticals a public company?

Gtree Pharmaceuticals is private company therefore does not currently have an official ticker symbol

Manufacturing · Australia · 11-50 Employees

View Company Info for Free

Overview

Headquarters

22 Nd Florida 248, Dalga, Queensland, 46...

Website

www.gtreepharma.com

Revenue

<$5 Million

Industry

Manufacturing

Pharmaceuticals

Business Services

Research & Development

About Gtree Pharmaceuticals

Gtree Pharmaceuticals is a biopharmaceutical company established in June 2014, focusing on the development of innovative drugs for ophthalmic and rare diseases. The company is currently conducting clinical trials for its lead product, GBT-201, aimed at treating dry eye syndrome and neurotrophic keratitis. Gtree Pharmaceuticals targets both domestic and international markets, particularly in South Korea and the United States. Their commitment to research and development positions them as a key player in the biopharmaceutical industry.Explore more

Is this data correct?

View contact profiles from Gtree Pharmaceuticals

SIC Code 28,283NAICS Code 32,325Show more

Gtree Pharmaceuticals Org Chart

Phone

Shinwook Kang

Division Vice President, Clinical Trial

Phone

Get the full picture

Compare Similar Companies to Gtree Pharmaceuticals

Compare insights from companies similar to Gtree Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.